Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Noorani A, Bornschein J, Lynch AG, Secrier M, Achilleos A, Eldridge M, Bower L, Weaver JMJ, Crawte J, Ong CA, Shannon N, MacRae S, Grehan N, Nutzinger B, O'Donovan M, Hardwick R, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Genome Res. 2017 Jun;27(6):902-912. doi: 10.1101/gr.214296.116. Epub 2017 May 2.

2.

Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.

Garcia E, Hayden A, Birts C, Britton E, Cowie A, Pickard K, Mellone M, Choh C, Derouet M, Duriez P, Noble F, White MJ, Primrose JN, Strefford JC, Rose-Zerilli M, Thomas GJ, Ang Y, Sharrocks AD, Fitzgerald RC, Underwood TJ; OCCAMS consortium.

Sci Rep. 2016 Sep 7;6:32417. doi: 10.1038/srep32417.

3.

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5.

PMID:
27595477
4.

Topic: Abdominal Wall Hernia - Epigastric hernia: choice of approach, repair, results, follow up.

Maldonado C, Daroch D, Maiz C, Bachler J, Crovari F, Boza C, Funke R, Köckerling F, Dabic D, Maric B, Perunicic V, Aho J, Samaha M, Antiel R, Dupont S, Ballman K, Sloan J, Bingener J, Macano C, Brookes A, Samee A, Davies S, Haleem A, Hayden S, Al-Aaraji S, Beardsmore D, Cox T, Huntington C, Blair L, Prasad T, Augenstein V, Heniford BT, Bauder A, Fischer J, Kovach S.

Hernia. 2015 Apr;19 Suppl 1:S208-11. doi: 10.1007/BF03355351. No abstract available.

PMID:
26518802
5.

The cost-effectiveness of wound-edge protection devices compared to standard care in reducing surgical site infection after laparotomy: an economic evaluation alongside the ROSSINI trial.

Gheorghe A, Roberts TE, Pinkney TD, Bartlett DC, Morton D, Calvert M; West Midlands Research Collaborative; ROSSINI Trial Investigators.

PLoS One. 2014 Apr 18;9(4):e95595. doi: 10.1371/journal.pone.0095595. eCollection 2014.

6.

Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial).

Pinkney TD, Calvert M, Bartlett DC, Gheorghe A, Redman V, Dowswell G, Hawkins W, Mak T, Youssef H, Richardson C, Hornby S, Magill L, Haslop R, Wilson S, Morton D; West Midlands Research Collaborative; ROSSINI Trial Investigators.

BMJ. 2013 Jul 31;347:f4305. doi: 10.1136/bmj.f4305.

7.

Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected].

Beardsmore DM, Verbeke CS, Davies CL, Guillou PJ, Clark GW.

J Gastrointest Surg. 2003 Jan;7(1):77-86; discussion 86-7. Erratum in: J Gastrointest Surg. 2003 May-Jun;7(4):583.

PMID:
12559188
8.

A psoas ganglion causing obstruction of the iliofemoral arteries.

Beardsmore D, Spark JI, MacAdam R, Macdonald D, Scott DJ.

Eur J Vasc Endovasc Surg. 2000 May;19(5):554-5. No abstract available.

PMID:
10828240
9.

Polytetrafluoroethylene (PTFE) femorodistal grafts with a distal vein cuff for critical ischaemia.

Wijesinghe LD, Beardsmore DM, Scott DJ.

Eur J Vasc Endovasc Surg. 1998 May;15(5):449-53.

PMID:
9633503

Supplemental Content

Loading ...
Support Center